Scott Huntington, MD, MPH, MSc
Cards
About
Titles
Associate Professor of Internal Medicine (Hematology)
Chief Quality Officer, Smilow Cancer Hospital and Yale Cancer Center; Chief, Inpatient Cancer MedicineBiography
Scott Huntington, MD, MPH is a clinician and researcher at the Yale School of Medicine specializing in the care of patients with lymphoma and chronic lymphocytic leukemia. He is an Associate Professor of Medicine (Hematology) and the Medical Director of Yale Cancer Center's Hematology Outpatient Program. Prior to joining Yale, he completed his hematology-oncology training and received a Master of Science in Health Policy Research at the University of Pennsylvania. Dr. Huntington serves as an investigator on clinical trials evaluating novel cancer therapeutics and is an active member of Yale’s Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, where he leads research focused on improving the delivery of complex cancer treatment during routine care.
Appointments
Hematology
Associate Professor on TermPrimary
Other Departments & Organizations
- Cancer Prevention and Control
- COPPER Center
- Hematology
- Internal Medicine
- Leukemia & Lymphoma Program
- Yale Cancer Center
- Yale Medicine
Education & Training
- Fellowship
- University of Pennsylvania (2015)
- MSc
- University of Pennsylvania, Health Policy (2015)
- Residency
- Vanderbilt University (2012)
- MPH
- Mount Sinai School of Medicine (2009)
- MD
- Mount Sinai School of Medicine (2009)
Research
Overview
Medical Subject Headings (MeSH)
Academic Achievements and Community Involvement
Clinical Care
Overview
Scott Huntington, MD, MPH is a physician and researcher at Yale School of Medicine specializing in the care of patients with lymphoma and chronic lymphocytic leukemia.
Dr. Huntington diagnoses and treats common lymphoma disorders, including chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and mantle cell lymphoma, in addition to rare types such as Hairy cell leukemia, primary mediastinal B-cell lymphoma (PMBCL) and gray zone lymphoma. Dr. Huntington also has leadership roles as the Chief Quality Officer for Smilow Cancer Center and the Firm Chief for the inpatient blood cancer service.
Dr. Huntington is an active researcher at Yale’s Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, where he leads research focused on improving the delivery of complex cancer treatment and improving patient outcomes. He is also an active clinical trial investigator, evaluating novel cancer therapeutics in individuals with CLL, Hodgkin lymphoma, and B cell non-Hodgkin lymphomas.
A recipient of the Conquer Cancer Foundation of ASCO Merit Award, Armstrong Founders Award, and 40 under 40 in Cancer, Dr. Huntington is an associate professor of internal medicine at Yale University School of Medicine.
Clinical Specialties
Fact Sheets
Hairy Cell Leukemia
Learn More on Yale MedicineNon-Hodgkin's Lymphoma
Learn More on Yale MedicineLymphoma
Learn More on Yale MedicineChronic Lymphocytic Leukemia (CLL)
Learn More on Yale Medicine
Yale Medicine News
Links & Media
News
- April 02, 2024
YCC Publications 2024
- December 18, 2023
Scott Huntington, MD, MPH, MSc, Named Chief Quality Officer
- October 02, 2023
ASCO Review 2023
- July 26, 2023
Thriving Against the Odds
Get In Touch
Contacts
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.